CrossGen Wealth’s CVS Health CVS Stock Holding History

CrossGen Wealth’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.55K	Hold	63	–	–	0.01%	171
2026 Q1	$4.51K	Buy	63 +1	+2%	+$77	﹤0.01%	166
2025 Q4	$4.94K	Buy	+62	New	+$4.89K	﹤0.01%	161

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

CrossGen Wealth's CVS Position: Q2 2026 in Review

CrossGen Wealth held its CVS Health (CVS) position steady in Q2 2026 at 63 shares worth $6.55K. The position accounts for 0.01% of the portfolio, ranked #171.

CrossGen Wealth first reported a position in CVS in Q4 2025 and has held it in 3 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

CrossGen Wealth held 63 shares of CVS Health worth $6.55K as of Q2 2026.
CrossGen Wealth left its CVS Health share count unchanged in Q2 2026.
CVS Health made up 0.01% of CrossGen Wealth's portfolio in Q2 2026, its #171 holding.
CrossGen Wealth first reported a position in CVS Health in Q4 2025 and has held it in 3 quarters since.
2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on CrossGen Wealth's 13F filing for Q2 2026, filed 24 Jul 2026.